Specialty / Expertise

Lymphoma

Research Interests

Translational and clinical studies in lymphoma, radioimmunotherapy, biological therapy, stem cell transplantation

Current Research Projects

Translational and clinical studies in lymphoma, radioimmunotherapy, biological therapy, stem cell transplantation

Research Staff

Training

Dr. Gopal received his MD from Emory University, Atlanta, GA. He completed his Internal Medicine Residency at the Duke University, Durham, NC. He was a Post-Doctoral Fellow in Oncology at the University of Washington, Seattle, WA.

Selected Publications:

Zhang MM, Gopal AK. Radioimmunotherapy-based conditioning regimens for stem cell transplantation. Semin Hematol 2008 45(2):118-125.

Pagel JM, Hedin N, Drouet L, Wood BL, Panelias A, Lin Y, Hamlin DK, Wilbur DS, Gopal AK, Green D, Appelbaum FR, Press OW. Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy. Blood 2008 111(4):2261-2268.

Pham RN, Gooley TA, Keeney GE, Press OW, Pagel JM, Greisman HA, Bensigner WI, Holmberg LA, Petersdorf SH, Maloney DG, Gopal AK. The impact of histologic grade on the outcome of high-dose therapy and autologous stell cell transplantationfor follicular lymphoma. Bone Marrow Transplant 2007 40(11):1039-1044.

Gopal A, Rajendran J, Gooley T, Pagel J, Petersdorf S, Maloney D, Eary J, Appelbaum, Press O. Myeloblative I-131 anti-CD-20 (tositimomab) radioimmunotherapy and Autologous Stem cell transplantation ASCT for adults > 60 years of age with Relapsed or Refractory B-Cell Lymphoma. J Clin Oncol, 2007 25(11):1396-1402.

Ying SX, Seal S, Abbassi N, Hockenbery DM, Kiem HP, Li X, Pagel JM, Gopal AK, Deeg HJ. Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines. Leukemia and Lymphoma 2007 67(12):5921-5928.

Gopal A, Pagel J, Rajendran J, Maloney D, Appelbaum F, Sorror M, Sandmaier B, Storb R, Press O. Improving the efficacy of reduced-intensity allogeneic transplantation for lymphoma using radioimmunotherapy. Biol Blood Marrow Transplant 2006 Jul;12(7):697-702.